Cargando…

Acute Viral Hepatitis Due to Co-infection With Hepatitis A and Hepatitis B in an Intravenous Drug User

Injection drug users are at high risk of contracting human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) due to parenteral exposure. Hepatitis A virus (HAV) is classically thought to be transmitted through the fecal-oral route, but injection drug use is increasin...

Descripción completa

Detalles Bibliográficos
Autores principales: Logemann, Shaina, Blinkhorn, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166325/
https://www.ncbi.nlm.nih.gov/pubmed/37168197
http://dx.doi.org/10.7759/cureus.37179
_version_ 1785038422445916160
author Logemann, Shaina
Blinkhorn, Richard
author_facet Logemann, Shaina
Blinkhorn, Richard
author_sort Logemann, Shaina
collection PubMed
description Injection drug users are at high risk of contracting human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) due to parenteral exposure. Hepatitis A virus (HAV) is classically thought to be transmitted through the fecal-oral route, but injection drug use is increasingly recognized as a risk factor. It is well documented that there is a high prevalence of total antibodies to HAV in injection drug users, although there is limited data about the prevalence of acute HAV in injection drug users. Acute viral hepatitis is most often due to HAV, HBV, or hepatitis E virus (HEV), and it is rare to have acute co-infection with these viruses. We report a case of acute viral hepatitis due to co-infection with both HAV and HBV in an injection drug user.
format Online
Article
Text
id pubmed-10166325
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-101663252023-05-09 Acute Viral Hepatitis Due to Co-infection With Hepatitis A and Hepatitis B in an Intravenous Drug User Logemann, Shaina Blinkhorn, Richard Cureus Internal Medicine Injection drug users are at high risk of contracting human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) due to parenteral exposure. Hepatitis A virus (HAV) is classically thought to be transmitted through the fecal-oral route, but injection drug use is increasingly recognized as a risk factor. It is well documented that there is a high prevalence of total antibodies to HAV in injection drug users, although there is limited data about the prevalence of acute HAV in injection drug users. Acute viral hepatitis is most often due to HAV, HBV, or hepatitis E virus (HEV), and it is rare to have acute co-infection with these viruses. We report a case of acute viral hepatitis due to co-infection with both HAV and HBV in an injection drug user. Cureus 2023-04-05 /pmc/articles/PMC10166325/ /pubmed/37168197 http://dx.doi.org/10.7759/cureus.37179 Text en Copyright © 2023, Logemann et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Logemann, Shaina
Blinkhorn, Richard
Acute Viral Hepatitis Due to Co-infection With Hepatitis A and Hepatitis B in an Intravenous Drug User
title Acute Viral Hepatitis Due to Co-infection With Hepatitis A and Hepatitis B in an Intravenous Drug User
title_full Acute Viral Hepatitis Due to Co-infection With Hepatitis A and Hepatitis B in an Intravenous Drug User
title_fullStr Acute Viral Hepatitis Due to Co-infection With Hepatitis A and Hepatitis B in an Intravenous Drug User
title_full_unstemmed Acute Viral Hepatitis Due to Co-infection With Hepatitis A and Hepatitis B in an Intravenous Drug User
title_short Acute Viral Hepatitis Due to Co-infection With Hepatitis A and Hepatitis B in an Intravenous Drug User
title_sort acute viral hepatitis due to co-infection with hepatitis a and hepatitis b in an intravenous drug user
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166325/
https://www.ncbi.nlm.nih.gov/pubmed/37168197
http://dx.doi.org/10.7759/cureus.37179
work_keys_str_mv AT logemannshaina acuteviralhepatitisduetocoinfectionwithhepatitisaandhepatitisbinanintravenousdruguser
AT blinkhornrichard acuteviralhepatitisduetocoinfectionwithhepatitisaandhepatitisbinanintravenousdruguser